Ixmyelocel-T: Completed Phase IIb enrollment

Aastrom completed enrollment of 86 patients in the double-blind, placebo-controlled, U.S. Phase IIb RESTORE-CLI trial evaluating intramuscular injections of VRCs. In February, the company reported int...